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21-activated kinases (PAKs) regulate many cellular
processes, including cytoskeletal rearrangement
and cell migration. In this study, we report a direct
and speciﬁc interaction of PAK1 with a 22-kD Ca
 
2
 
 
 
-bind-
ing protein, CIB1, which results in PAK1 activation both
in vitro and in vivo. CIB1 binds to PAK1 within discrete
regions surrounding the inhibitory switch domain in a
calcium-dependent manner, providing a potential mecha-
nism of CIB1-induced PAK1 activation. CIB1 overexpres-
sion signiﬁcantly decreases cell migration on ﬁbronectin
p
 
as a result of a PAK1-and LIM kinase–dependent increase
in coﬁlin phosphorylation. Conversely, the RNA interfer-
ence–mediated depletion of CIB1 increases cell migration
and reduces normal adhesion-induced PAK1 activation
and coﬁlin phosphorylation. Together, these results dem-
onstrate that endogenous CIB1 is required for regulated
adhesion-induced PAK1 activation and preferentially in-
duces a PAK1-dependent pathway that can negatively
regulate cell migration. These results point to CIB1 as a
key regulator of PAK1 activation and signaling.
 
Introduction
 
Upon adhesion to ECM, cytoskeletal rearrangements occur that
lead to cell spreading, actin turnover, and cell migration. The
p21-activated kinase (PAK) family of serine/threonine kinases
plays a significant role in regulating these processes (Kiosses et
al., 1999; Sells et al., 1999). The best-described upstream acti-
vators of the PAK family are the Rho GTPases Rac and Cdc42.
These small GTPases bind within the NH
 
2
 
 terminus of PAK,
resulting in PAK autophosphorylation and increased PAK cata-
lytic activity (Leung et al., 1994).
Although it is generally considered that PAK1 activity is
primarily regulated via small GTPases, GTPase-independent
mechanisms have also been described. Thus, PAK1 activity
can be stimulated by sphingosine (Bokoch et al., 1998; Lian et
al., 1998), by the actin-binding protein filamin A (Vadlamudi
et al., 2002), and by PI3 kinase (Papakonstanti and Stournaras,
2002). Additional PAK1-binding proteins include the family of
PAK-interacting exchange factors (Cool/PIX; Bagrodia et al.,
1998; Daniels et al., 1999), Etk/Bmx (epithelial and endothe-
lial/bone marrow tyrosine kinase gene in chromosome X;
Bagheri-Yarmand et al., 2001), and p35/Cdk5 kinase (Rashid
et al., 2001).
Once activated, PAK1 affects multiple pathways to regu-
late cytoskeletal dynamics and cell migration. However, vari-
ous studies have described both a positive and negative role for
PAK1 in regulating cell migration. For example, overexpres-
sion of constitutively active (ca) PAK1 mutants promotes cell
migration on collagen (Sells et al., 1997, 1999), possibly via
p38-MAPK (Adam et al., 2000; Dechert et al., 2001), whereas
in other studies, active PAK1 mutants inhibit cell migration on
fibronectin
 
 
 
(FN; Kiosses et al., 1999). Furthermore, PAK1
kinase activity is required for directional or haptotactic cell
migration (Sells et al., 1999; Adam et al., 2000) but not for
random cell movement (Sells et al., 1999). Inhibitory effects of
PAK1 on migration appear to involve PAK1 activation of cy-
toskeletal regulatory proteins such as Lin-11/Isl-1/Mec-3
 
 
 
kinase
(LIMK) 1 (Edwards et al., 1999), which, in separate studies,
phosphorylates and inactivates the actin depolymerizing factor
cofilin (Arber et al., 1998; Yang et al., 1998). Phosphorylation
and inactivation of cofilin diminished cell polarity (Dawe et al.,
2003; Ghosh et al., 2004) and directed cell movement (Ghosh
et al., 2004). However, mechanisms by which PAK1 couples to
this negative regulatory pathway are not well understood.
In this study, we report a novel Rac/Cdc42-independent
pathway of PAK1 activation by an EF hand–containing regu-
latory molecule termed CIB1 (also CIB, calmyrin, and KIP
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[kinase-interacting protein]). CIB1 was originally identified as
a 22-kD protein that binds to the platelet integrin 
 
 
 
IIb cytoplas-
mic tail (Naik et al., 1997). However, CIB1 is widely distrib-
uted and is likely to have cellular roles that are independent of
this platelet-specific integrin. CIB1 contains four EF hand mo-
tifs, two of which bind calcium (Gentry et al., 2004; Yamniuk
et al., 2004), and is NH
 
2
 
-terminally myristoylated. CIB1 can
bind presenilin-2 (Stabler et al., 1999), Rac3 (Haataja et al.,
2002), FAK (Naik and Naik, 2003), DNA-dependent protein
kinase (Wu and Lieber, 1997), and fibroblast growth factor–
and serum-inducible kinases (Kauselmann et al., 1999). How-
ever, the functions of endogenous CIB1 and its relationship to
relevant intracellular binding partners have not been clearly de-
lineated. We report that CIB1 binds to and specifically acti-
vates PAK1 both in vitro and in vivo via a specific CIB1-bind-
ing region within PAK1. The CIB1–PAK1 interaction is
required for normal adhesion-induced PAK1 activation, which
negatively regulates cell migration across FN and appears to
involve a PAK1–LIMK–phosphocofilin pathway. Therefore,
our results establish CIB1 as a key regulator of PAK1 activa-
tion and migration.
 
Results
 
CIB1 interacts directly with PAK1
 
To learn about the in vivo function of CIB1, we sought to iden-
tify endogenous CIB1-interacting proteins first by immunopre-
cipitating CIB1 from platelet lysates. Immunoblotting with an
antiphosphoserine antibody revealed a single reactive band of
 
 
 
66 kD that specifically coimmunoprecipitated with CIB1
(Fig. 1 A, left). This band was also evident when immunoblot-
ting with an anti-PAK antibody (Fig. 1 A, middle), indicating
that CIB1 coimmunoprecipitates with a member of the PAK
family. Furthermore, whole platelet lysates were positive for
PAK expression (Fig. 1 A, right). Because platelets are primary
hematopoietic cells that exist in suspension, we also asked
whether endogenous CIB1 and PAK coimmunoprecipitate in
an adherent cell line (rat embryo fibroblast [REF] 52). Al-
though CIB1 interacted minimally with PAK in suspended
REF52 cells, a dramatic increase in CIB1 binding to PAK was
observed within 30 min of cell adhesion to FN. This decreased
slightly with extended times of adhesion (Fig. 1 B), suggesting
an adhesion-dependent regulation of the endogenous CIB1–
PAK interaction.
Coimmunoprecipitation of endogenous PAK with CIB1
does not indicate whether CIB1 interacts directly with PAK or
indirectly via other proteins. To address this, we used purified
recombinant CIB1 and PAK1 in solid-phase binding assays
and found that PAK1 bound to immobilized CIB1 in a direct,
saturable manner (Fig. 1 C), whereas the PAK2 isoform exhib-
ited minimal binding (Fig. 1 D).
 
Identification of the CIB1-binding site 
within PAK1
 
To begin identifying the CIB1-binding site within PAK1, we
assessed the CIB1-binding activity of a PAK1 NH
 
2
 
-terminal
deletion mutant lacking the first 164 amino acids (N165-
PAK1). This mutant failed to bind immobilized CIB1, indicat-
ing that the CIB1-binding site is probably within the PAK1
NH
 
2
 
 terminus (Fig. 2 A). Further delineation using peptide
SPOT technology (Frank, 2002) demonstrated that CIB1 re-
acts with peptides corresponding to two distinct sites within
PAK1 (Fig. 2 B); the first maps to aa 50–61 (site I) just up-
stream of the p21-binding domain (PBD; aa 70–113), and the
second maps to aa 130–137 (site II) within the NH
 
2
 
-terminal
autoinhibitory domain. Sequence homology searches revealed
that sites I and II share little sequence identity with other
closely related PAK members (30–50% identity to corre-
sponding regions of PAK2 and PAK3) and with other known
proteins, which is consistent with a relative lack of CIB1 bind-
ing to PAK2.
Figure 1. CIB1 binds to PAK1 in vivo and in vitro. (A) Immunoprecipitates
from platelet lysates were immunoblotted with an antiphosphoserine (left)
or anti-PAK (middle) antibody. Whole cell lysates (WCL) were probed with
an anti-PAK antibody (right; n   3 experiments). (B) CIB1 and control IgY
immunoprecipitates from lysates of REF52 cells in suspension or adhered
to FN were immunoblotted for PAK (top) and CIB1 (bottom). (C) Solid-
phase binding assays using immobilized CIB1 and soluble PAK proteins.
Increasing concentrations of His-PAK1 were added to wells coated with
and without immobilized CIB1. His-PAK1 binding was detected using an
anti-His antibody. (D) PAK isozyme–binding specificity was determined by
adding GST-PAK1 or GST-PAK2 to immobilized CIB1. PAK binding was
detected with an anti-GST antibody. WB, Western blot; IP, immunoprecip-
itates. Error bars represent SEM. 
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To further confirm these binding sites, we used pull-down
assays to test the ability of synthetic peptides (corresponding to
sites I and II) to inhibit soluble CIB1 binding to PAK1 that was
immobilized on Ni
 
2
 
 
 
–nitrilotriacetic acid (NTA) agarose beads.
Preincubation of CIB1 with either site I or II peptide significantly
inhibited CIB1 binding to PAK1, although the site II peptide ap-
peared to be slightly more effective. In contrast, corresponding
scrambled peptides had a minimal effect (Fig. 2 C). In addition, a
peptide lacking the last four amino acids of site II (
 
 
 
KTSN and
site II
 
 
 
) but possessing additional upstream NH
 
2
 
-terminal resi-
dues did not inhibit CIB1 binding to PAK1. This suggests a role
of KTSN site II residues in PAK1 recognition of CIB1 (Fig. 2 C).
To further establish the importance of these CIB1-binding
sites within the intact PAK1 molecule, the COOH-terminal
K135/T136/S137 residues of site II were mutated to alanines
(myc-AAAPAK1), and these PAK1 mutants were coexpressed
with CIB1 (Fig. 2 D, right). These mutations significantly dimin-
ished the ability of PAK1 to coimmunoprecipitate with CIB1.
However, overexpression of an AAA site II construct in which
the NH
 
2
 
-terminal fragment encompassing site I (aa 8–68) was de-
leted (myc-
 
 
 
/AAAPAK1) did not result in an additional loss of
PAK1 binding to CIB1 (Fig. 2 D, left). These results indicate that
although both sites in PAK1 may contribute to the CIB1–PAK1
interaction, site II appears to play a more critical role than site I.
 
Active Cdc42 and Ca
 
2
 
 
 
 affect the 
interaction between CIB1 and PAK1
 
Because CIB1 binds near the PBD within PAK1, we asked
whether Cdc42 affects the interaction between CIB1 and
PAK1. Competition binding assays indicated that PAK1 bind-
ing to immobilized CIB1 was largely inhibited by soluble, ac-
tive Cdc42-GTP
 
 
 
S, but not by inactive Cdc42–GDP (Fig. 3 A).
A specific interaction between CIB1 and PAK1 was further
confirmed by the ability of soluble CIB1 to inhibit PAK1 bind-
ing to immobilized CIB1 (Fig. 3 A).
Because CIB1 contains two Ca
 
2
 
 
 
-binding EF hand do-
mains, we next asked whether PAK1 binding to CIB1 was Ca
 
2
 
 
 
dependent. In the absence of EGTA, PAK1 binding to immobi-
lized CIB1 was maximized at 1 
 
 
 
M Ca
 
2
 
 
 
 and was not further
enhanced by 1 mM Ca
 
2
 
 
 
. However, with decreasing free Ca
 
2
 
 
 
concentrations, PAK1 binding to immobilized CIB1 dimin-
ished significantly at or below 10
 
 
 
8
 
 M free Ca
 
2
 
 
 
 (Fig. 3 B),
suggesting that physiologic Ca
 
2
 
 
 
 concentrations modulate the
interaction between CIB1 and PAK1.
 
CIB1 directly stimulates PAK1 activity 
both in vitro and in vivo
 
Binding of activated Rac and Cdc42 to members of the PAK
family results in PAK autophosphorylation and stimulation of
Figure 2. Identification of CIB1-binding sites within the PAK1 NH2 terminus. (A) CIB1 binds to full-length wild-type GST-PAK1 (wtPAK1) and GST-PAK1
K298A (kdPAK1) but not the NH2-terminal deletion GST-N165-PAK1. Solid-phase binding assays were performed as in Fig. 1 C, and soluble GST-PAK1,
GST-PAK1 K298A, and GST-N165-PAK1 were added to wells coated with CIB1. (B) Delineation of the CIB1-binding sites in the PAK1 NH2-terminal sequence
by SPOT peptide method. Top and middle panels show two sets of CIB1 reactive spots labeled as sites I and II relative to the PBD- or Rac/Cdc42-binding
sites (residues 70–113, dotted boxes). The bottom panel indicates the inhibitory switch (IS) and kinase inhibitor (KI) domains. Sequences of corresponding
CIB1-binding sites are below. (C) Inhibition of CIB1 binding to PAK1 with site I and II peptides. Ni-NTA agarose beads loaded with purified His-PAK1
were added to recombinant CIB1 that was preincubated with and without PAK1 peptides corresponding to sites I and II and scrambled sites I and II.
Peptide sequences of sites I, II, and II  are shown below. The graph represents densitometry of affinity precipitates probed for CIB1 and normalized to His-
PAK1 that was immunoblotted from the same membrane. Data represent SEM from two independent experiments (error bars). (D) Loss of CIB1 binding to
site I and II PAK1 mutants. Clarified lysates from HEK293 cells cotransfected with CIB1 and myc wild-type (wt)PAK1, myc-PAK1 siteIAAA (myc-AAAPAK1),
or myc-PAK1 siteI /siteIIAAA (myc- /AAA PAK1) were immunoprecipitated with a control IgG or anti-CIB1 antibody and with samples immunoblotted for
myc (top) and CIB1 (bottom; n   4). Western blots of the input expression of CIB1 and myc-tagged wtPAK1 (closed arrowheads), AAAPAK (closed arrow-
heads), or  /AAAPAK1 (open arrowheads). 
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kinase activity. Because both Cdc42-GTP
 
 
 
S and CIB1 bind to
PAK1 within the NH
 
2
 
-terminal regulatory domain, we explored
whether CIB1 also activates PAK1. In vitro kinase assays dem-
onstrated that His-PAK1 alone exhibited little autophosphoryla-
tion and kinase activity, but, as expected, 25 nM Cdc42-GTP
 
 
 
S
increased His-PAK1 kinase activity threefold (Fig. 3 C). Inter-
estingly, 25 nM CIB1 alone stimulated both PAK1 autophos-
phorylation and kinase activity to an equal or slightly greater
degree than an equimolar amount of Cdc42-GTP
 
 
 
S. Moreover,
a twofold higher concentration of CIB1 (50 nM) further in-
creased His-PAK activation to sixfold above basal level (Fig.
3 C), indicating that CIB1 directly activates PAK1 indepen-
dently of small GTPases.
To examine whether CIB1 can activate PAK1 in vivo, we
overexpressed CIB1 in human embryonic kidney (HEK) 293
cells and tested for activation of endogenous PAK1. Consistent
with previous reports (Price et al., 1998; Kiosses et al., 1999),
vector-transfected cells that were held in suspension exhibited
minimal PAK1 activation, whereas cell adhesion to FN up-
regulated PAK1 activation (Fig. S1 A, available at http://
www.jcb.org/cgi/content/full/jcb.200502090/DC1). In contrast,
CIB1-overexpressing cells that were held in suspension
showed a higher level of PAK1 activation than did vector con-
trol cells that were further increased upon cell adhesion relative
to the vector (Fig. S1 A). This indicates that CIB1 can stimu-
late PAK1 activity in vivo
 
.
 
Because our in vitro binding studies indicate a calcium-
dependent interaction between CIB1 and PAK1 (Fig. 3 B), we
also asked whether calcium levels affect PAK1 activation in
vivo. Pretreatment of control and CIB1-overexpressing cells
with the Ca
 
2
 
 
 
 chelator BAPTA-AM resulted in decreased adhe-
sion-dependent PAK activation (Fig. S2, available at http://
www.jcb.org/cgi/content/full/jcb.200502090/DC1), suggesting a
Ca
 
2
 
 
 
-dependent component to PAK1 signaling.
 
CIB1 specifically activates PAK1 
independently of Rho GTPases and 
affects cell morphology
 
To better study the consequences of the CIB1–PAK1 interac-
tion, we chose a nontransformed REF52 cell line, which has
been well characterized with respect to cytoskeletal organiza-
tion, cell spreading, and migration (Pavalko and Burridge,
1991). As predicted by the conserved CIB1-binding sites in rat
PAK1 (Fig. S1 B), we found that overexpression of human
CIB1 in suspended or FN-adherent REF52 cells activated en-
dogenous rat PAK1 to a similar extent as human PAK1 in
HEK293 cells (at least twofold; Fig. 4 A). Although our in
vitro binding studies indicated that CIB1 binds to the PAK1,
but not to the PAK2, isoform (Fig. 1 D), it is possible that CIB1
may bind to and activate the more closely related PAK3 isoform.
However, under the same conditions in which we observed
CIB1-induced PAK1 activation, overexpressed CIB1 did not
stimulate PAK3 activity in REF52 cells (Fig. 4 A).
Because PAK1 can also be activated by Rac and Cdc42
(Manser et al., 1994; Bagrodia et al., 1995), we asked whether
these GTPases contributed to the CIB1-induced PAK1 activa-
tion that was observed in cells adherent to FN. Inactivation of
Rho, Rac, and Cdc42 with toxin B from 
 
Clostridium difficile
 
(Just et al., 1995; Chaves-Olarte et al., 2003) did not block
initial (30 min) adhesion-induced PAK1 activation in control-
transfected cells that were replated on FN (Fig. 4 B) but did
attenuate PAK1 activation in control cells that were adhered
for extended times (180 min). These results suggest a role for
Rho GTPases in PAK1 activation at these later time points.
Importantly, in cells overexpressing CIB1, toxin B did not in-
hibit PAK1 activation at each time tested, further demonstrat-
Figure 3. Cdc42 and Ca
2  affect the CIB1–PAK interaction, and CIB1
stimulates PAK1 activity in vitro. (A) Activated Cdc42-GTP S or CIB1, but
not inactive Cdc42-GDP, competes with immobilized CIB1 for binding to
soluble His-PAK1. Soluble His-PAK1 was incubated with increasing concen-
trations of soluble CIB1 or Cdc42 that was preloaded with GDP or GTP S
before incubation with immobilized CIB1. (B) Determination of Ca
2 -depen-
dent binding of His-PAK1 to CIB1. His-PAK1 was diluted in buffer contain-
ing 0–5 mM EGTA before addition to immobilized CIB1. Approximate free
Ca
2  concentrations were calculated using the MaxChelator program (Bers
et al., 1994). (C) Stimulation of recombinant His-PAK1 activity by recombi-
nant CIB1 or Cdc42-GTP S. His-PAK1 autophosphorylation was assayed in
the absence (top) or presence of myelin basic protein (MBP) to detect active
kinase (middle). White lines indicate that intervening lanes have been
spliced out. Myelin basic protein phosphorylation ([
32P]MBP) from densitom-
etry analysis induced by His-PAK1 alone was assigned a value of 1 (bar
graph). Data represent means   SEM (error bars; n   3). 
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ing that CIB1 can stimulate PAK1 activity in the absence of
active Rho GTPases. The inhibition of Rho GTPases by toxin B
was confirmed with precipitation assays to detect active
Cdc42 and Rac under the same conditions tested in Fig. 4 B
(Fig. 4 C). In agreement with our toxin B results, the coex-
pression of both dominant negative (DN) Rac and Cdc42 did
not significantly inhibit PAK1 activation upon adhesion to FN
(Fig. S3 A, available at http://www.jcb.org/cgi/content/full/
jcb.200502090/DC1) but did attenuate PAK1 activation with
prolonged adhesion to FN. These results further confirm an
initial GTPase-independent component to PAK1 activation
upon cellular adhesion to FN.
Because PAK1 activity modulates cytoskeletal architec-
ture (Manser et al., 1997; Sells et al., 1997) and CIB1 stimu-
lates PAK1 activity, we asked whether CIB1 overexpression
also modulates cytoskeletal architecture. CIB1-transfected
cells exhibited a distinct absence of large, mature focal adhe-
sions that are normally found throughout stably adherent cells
(Fig. S4 D, available at http://www.jcb.org/cgi/content/full/
jcb.200502090/DC1), which is consistent with the loss of focal
adhesions in overexpressed active PAK1 mutants (Manser et
al., 1997; Sells et al., 1997). Furthermore, CIB1-overexpress-
ing cells showed extensive membrane ruffling, with CIB1 lo-
calizing to these areas of increased actin dynamics (Fig. S4 A,
merge). CIB1 overexpression also resulted in decreased cell
spreading, and cells became asymmetrical with multiple non-
polarized extensions (Fig. S4, A and B). The exogenous ex-
pression of CIB1 with myc-wtPAK1 revealed that both CIB1
and PAK1 are distributed within the cytoplasm and that CIB1
is also expressed within the nucleus (Fig. S4). Importantly, dur-
ing cell spreading upon readhesion to FN, CIB1 and PAK1 are
prominently colocalized within membrane ruffles (Fig. S4 E,
left and inset). Furthermore, with extended adhesion to FN
(1–2 h), we observed persistent CIB1–PAK1 colocalization
within these membrane structures (Fig. S4 E; middle, right, and
insets), providing evidence for an interaction between CIB1
and PAK1 in subcellular areas of dynamic actin remodeling.
 
CIB1 negatively regulates cell migration 
on FN
 
Active PAK1 mutants are reported to have both stimulatory
and inhibitory effects on cell migration, depending on the type
and concentration of ECM substrate (Sells et al., 1997;
Kiosses et al., 1999). Therefore, we asked whether overex-
pression of CIB1 would induce a positive or negative PAK1-
dependent effect on cell migration toward FN. Haptotactic
migration assays were performed with serum-starved cells that
were transfected either with CIB1 or vector control. Visualiza-
tion of CIB1-transfected cells on the underside of the transwell
membrane (Fig. 5 A, middle) indicated a dramatic 2.5-fold de-
crease in migrating cells relative to vector control or GFP-
expressing cells, as quantified in Fig. 5 A (left). To determine
whether the inhibitory effect of CIB1 on cell migration was
PAK1 dependent, CIB1 was cotransfected with kinase-dead
(kd) PAK1-K299R (kdPAK1), which restored cell migration
to control levels (Fig. 5 A, left). A role for PAK1 in the CIB1-
induced inhibition of migration was further established with
mouse embryo fibroblasts (MEFs) that were derived from
PAK1-null (PAK
 
 
 
/
 
 
 
) and wild-type (PAK
 
 
 
/
 
 
 
) mice (unpub-
lished data). Consistent with the results in Fig. 5 A, PAK1
 
 
 
/
 
 
 
cells overexpressing CIB1 exhibited a twofold decrease in
haptotactic cell migration toward FN relative to GFP vector
control, whereas PAK1
 
 
 
/
 
 
 
 MEFs expressing CIB1 migrated
normally (Fig. 5 B). This demonstrates a requirement for
PAK1 in the CIB-induced inhibition of migration. Interest-
ingly, the lack of PAK1 in PAK1
 
 
 
/
 
 
 
 MEFs did not impair cell
migration, suggesting that these cells possess compensatory
migration pathways and/or that PAK1 is not required for hap-
totactic migration toward FN under these conditions.
Figure 4. CIB1 specifically stimulates PAK1 activity in vivo independently
of small GTPases. (A) CIB1 specifically activates the PAK1 isoform. Endog-
enous PAK1 (bottom left) and PAK3 (bottom right) were immunoprecipi-
tated from lysates prepared from vector- and CIB1-transfected REF52 cells
either held in suspension or replated on FN for 20 min. Immunoprecipi-
tated PAK was subjected to in vitro kinase assays using myelin basic pro-
tein (MBP) as substrate. The bar graph (top) depicts [
32P]MBP values after
normalization for PAK immunoprecipitation. [
32P]MBP values from vector
control cells were set as 1. Data represent SEM from two independent ex-
periments (error bars). (B) GTPase-independent PAK1 activation. Serum-
starved vector and CIB1-transfected REF52 cells held in suspension were
treated with or without 100 ng/ml toxin B and either left in suspension or
adhered to FN. Cells were lysed at the indicated times, and immunopre-
cipitated endogenous PAK1 was subjected to in vitro kinase assays using
myelin basic protein as substrate. White lines indicate that intervening
lanes have been spliced out; n   3. (C) Efficacy of toxin B treatment was
determined by assaying REF52 cell lysates for activated Rac1 and Cdc42
(see PAK1 kinase and Rac/Cdc42 activation assays). Affinity precipitates
were analyzed by Western blotting for both Rac1 and Cdc42. 
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Because CIB activates PAK1 and inhibits cell migration,
we asked whether ca PAK1 affected migration in a similar
manner. REF52 cells overexpressing either ca PAK1-T423E
(caPAK1) or CIB1 plus wtPAK1 exhibited a twofold decrease
in cell migration toward FN as compared with cells expressing
either wtPAK1 or kdPAK1 (Fig. S5 A, available at http://
www.jcb.org/cgi/content/full/jcb.200502090/DC1). Because ac-
tive PAK1 has been shown to stimulate migration of another
cell type, NIH3T3, across collagen (Sells et al., 1999), we tested
the effects of caPAK1 on NIH3T3 cell migration across FN.
Similar to REF52 cells, NIH3T3 cells overexpressing caPAK1
also exhibited an approximately twofold decrease in haptotactic
migration compared with cells expressing wtPAK1 (Fig. S5 B).
Moreover, CIB1 overexpression in NIH3T3 cells resulted in a
similar inhibition of haptotactic migration toward FN (Fig.
S5 B). Apparent differences in the effects of caPAK1 are most
Figure 5. CIB1 overexpression inhibits, and endogenous CIB1 depletion increases, cell migration. (A) Serum-starved REF52 cells transfected with GFP vector,
control vector, or CIB1   kdPAK1 or kdLIMK1 were subjected to haptotactic transwell migration assays toward FN. Transfected cells on either the top mem-
brane (nonmigrating cells) or bottom membrane (migrating cells) were visualized by staining for CIB1 expression (middle). Control migration was visualized
by GFP fluorescence (right). Cells overexpressing vector CIB1   kdPAK1 or   kdLIMK1 on the top and bottom membranes were also stained as described in
migration assays and were counted. Migration is represented as the percentage of the total number of transfected cells from the upper and lower mem-
branes (left). Data represent means   SEM (n   3). (B) MEFs derived from wild-type (PAK
 / ) and PAK1-null (PAK
 / ) mice were transfected with GFP vec-
tor or CIB1. Serum-starved cells were assayed for haptotactic migration toward 3  g/ml FN, and migration was determined as in A (left). Data represent
means   SEM (n   4). Right panels show representative images of migrated transfected cells (green, top) and phalloidin staining from the same field (red,
bottom). (A and B) Bars, 20  m. (C) HeLaS3 (left) and REF52 (right) cells were mock transfected or transfected with control or specific CIB1 siRNA and sub-
jected to haptotactic transwell migration assays toward FN (as in A). Data represent means   SEM (error bars; n   4 for each cell type). Inset blots show
representative endogenous CIB1 protein expression and nonspecific (NS) band or PAK1 expression from the same blot as the loading control.CIB1 ACTIVATION OF PAK1 REGULATES CELL MIGRATION • LEISNER ET AL. 471
likely a result of the type and concentration of matrix used in
this study (5  g/ml FN) versus the 50  g/ml of collagen that
were used by Sells et al. (1999). Collectively, our results dem-
onstrate not only an inhibitory role for PAK1 kinase activity in
cell migration toward FN but also further implicate PAK1 in
mediating CIB1-induced inhibition of cell migration.
A potential downstream effector that may contribute to
the CIB1-induced inhibition of cell migration is LIMK1 be-
cause PAK1 directly activates LIMK1 (Edwards et al., 1999),
which then phosphorylates and inactivates cofilin (Arber et al.,
1998; Yang et al., 1998). To test this hypothesis, we cotrans-
fected CIB1 with kd LIMK1-D460N (kdLIMK1) into REF52
cells. Migration was rescued in cells expressing both CIB1 and
kdLIMK1 (Fig. 5 A, left), indicating that CIB1–PAK1 signal-
ing to LIMK1 contributes to the inhibitory effects of CIB1 on
cell migration. Equivalent CIB1 expression levels were con-
firmed by immunoblotting (see Fig. 7 C, right).
Because overexpressed CIB1 inhibited cell migration, we
asked whether decreased endogenous CIB1 expression by RNA
interference would have the converse effect on cell migration.
Transfection of short inhibitory (si) RNA duplexes that target
CIB1 mRNA in two separate cell lines, HeLaS3 and REF52,
caused a significant decrease in endogenous CIB1 protein levels
without affecting PAK1 expression (Fig. 5 C, insets). Reduced
CIB1 expression resulted in a striking five- and threefold in-
crease in haptotactic cell migration toward FN in both HeLaS3
and REF52 cells, respectively, whereas a control siRNA was
without effect (Fig. 5 C). Altogether, these results indicate that
endogenous CIB1 negatively regulates cell migration across FN.
Endogenous CIB1 affects PAK1 
activation
We next asked whether the reduction of endogenous CIB1 af-
fected endogenous PAK1 activation. Upon adhesion to FN,
PAK1 activation in CIB1-depleted cells was markedly reduced
compared with control cells at all times tested except 2.5 h (Fig. 6
A). At this later time point, when PAK1 activation in control cells
had diminished, PAK1 activation in CIB1-depleted cells (REF52
cells, Fig. 6 A; and HeLaS3 cells, not depicted) was moderately
elevated, suggesting a disruption of the normal regulation of
PAK1 activation. Potential candidates to mediate this later PAK1
activation are the GTPases, Rac, and/or Cdc42. Interestingly, at
3 h of adhesion, increased Cdc42, but not Rac, activity was ob-
served in CIB1-depleted cells compared with control cells (Fig.
6 B). This suggests that in CIB1-depleted cells, Cdc42 is the pre-
dominant GTPase mediating the late up-regulation of PAK1 acti-
vation. Active Cdc42 promotes the formation of filopodia and
microspikes (Nobes and Hall, 1995). Consistent with increased
Cdc42 activity at 3 h of adhesion to FN, immunofluorescence
analysis of phalloidin-stained cells that adhered for 3 h revealed
that CIB1-depleted cells also exhibited extensive filopodia and
polarity (Fig. 6 C, right) relative to control cells (Fig. 6 C, left).
CIB1 affects downstream signaling to 
cofilin
The previous experiments demonstrated that endogenous CIB1
regulates endogenous PAK1 activation and that CIB1-induced
inhibition of cell migration requires PAK1 and LIMK1 activ-
ity. Presently, the only known substrate of LIMK1 is the actin
depolymerizing and severing protein cofilin (Arber et al.,
1998). Nonphosphorylated active cofilin (Yang et al., 1998) is
required for rapid actin filament turnover and cell motility
(Chen et al., 2001; Dawe et al., 2003). Therefore, we assessed
cofilin phosphorylation in cells under- and overexpressing
CIB1. CIB1-depleted REF52 cells exhibited decreased phos-
phorylation of endogenous cofilin upon adhesion to FN, which
persisted up to 3 h (Fig. 7 A); conversely, CIB1-overexpressing
cells showed increased cofilin phosphorylation (Fig. 7 C, left).
Decreased cofilin phosphorylation in CIB1-depleted cells fur-
ther links CIB1 to a PAK1–LIMK–cofilin pathway.
To determine whether PAK1 signaling to LIMK1 was re-
quired for the CIB1-induced increase in cofilin phosphorylation,
we coexpressed CIB1 with kdPAK1 or kdLIMK1. Coexpression
of CIB1 with either kdPAK1 or kdLIMK1 blocked the CIB1-
induced increase in cofilin phosphorylation (Fig. 7 C, left). To
confirm that the decreased cofilin phosphorylation observed in
cells coexpressing CIB1 with kdPAK1 or kdLIMK1 was not
caused by decreased CIB1 expression, lysates were analyzed for
CIB1, PAK1, and LIMK1 expression (Fig. 7 C, right), which
Figure 6. CIB1 is required for adhesion-induced PAK1 activation, and
loss of CIB1 disrupts PAK1/GTPase signaling. (A) Mock, control, or spe-
cific CIB1 siRNA-transfected REF52 cells were either held in suspension or
replated onto FN-coated dishes and were lysed at the indicated times.
Immunoprecipitated endogenous PAK1 was subjected to in vitro kinase as-
says (n   3). (B) Control or CIB1 siRNA-transfected REF52 cell lysates
were assayed for activated and total Rac1 and Cdc42. CIB1 knockdown
in REF52 cells was confirmed by immunoblotting cell lysates for endoge-
nous CIB1 expression (right) with ERK as a loading control from the same
membrane. (C) REF52 cells transfected with control (left) or CIB1 siRNA
(right) were replated on FN for 3 h and were stained with phalloidin.
Images are representative of two separate experiments. Bars, 20  m.JCB • VOLUME 170 • NUMBER 3 • 2005 472
showed no difference in CIB1 levels among transfected cells.
Therefore, these results demonstrate that CIB1-mediated inhi-
bition of cell migration most likely occurs via PAK1–LIMK-
dependent phosphorylation and inactivation of cofilin.
Discussion
In this study, we show that CIB1 binds directly to PAK1 to regu-
late PAK1 activation, cell spreading, and cell migration. CIB1
binding to PAK1 is calcium dependent and is inhibited by active
GTP-Cdc42. The CIB1-binding sites within PAK1 map to the
NH2-terminal residues 130–137 (site II) within the inhibitory
switch (IS) domain, thereby providing a mechanism by which
CIB1 directly activates PAK1 both in vitro and in vivo. In addi-
tion, CIB1 overexpression and depletion experiments indicate an
important role for endogenous CIB1 in activating endogenous
PAK1 upon cell adhesion and in suppressing cell migration to-
ward FN. CIB1 appears to suppress cell migration by signaling
to PAK1, thereby promoting a LIMK-dependent phosphoryla-
tion and inactivation of the actin regulatory protein cofilin.
Our results show that purified CIB1 activates PAK1 in
vitro independently of small GTPases. However, because the
Rho GTPases Rac and Cdc42 are the best-characterized PAK
activators and because CIB1 reportedly binds directly to Rac3
(Haataja et al., 2002), it was necessary to determine whether
CIB1 also activates PAK1 in vivo independently of small GTP-
ases. In support of this possibility, CIB1 and Cdc42 compete
for binding to PAK1 in vitro. We extended this observation in
vivo by assessing PAK1 activation in cells in which Rac and
Cdc42 were inhibited by toxin B or DN mutants. Because nei-
ther toxin B nor DN Rac and Cdc42 inhibited the peak of
PAK1 activation, which was induced upon cell adhesion in
vector control cells, it appears that molecules other than Rac
and Cdc42 (for example CIB1) might contribute to the initial
adhesion-induced PAK1 activation. This is also consistent with
the observation that CIB1-depleted cells exhibit impaired
PAK1 activation immediately upon cell adhesion. However,
with extended adhesion to FN, PAK1 activation in control cells
was sensitive to both toxin B and DN Rac/Cdc42, implicating a
role for Rac- and Cdc42-mediated PAK1 activation at these
later time points. Consistent with this observation, prolonged
adhesion resulted in an apparent CIB1-independent up-regula-
tion of PAK1 activation in CIB1-depleted cells. In contrast,
PAK1 activation in CIB1-overexpressing cells was insensitive
to toxin B at all times tested, demonstrating the ability of CIB1
to override any GTPase component of PAK1 activation. These
results further demonstrate that CIB1 can activate PAK1 in
vivo independently of small GTPases.
CIB1 has two putative binding sites within PAK1 NH2-
terminal residues (site I, aa 50–60; and site II, aa 130–137) that
flank the Rac/Cdc42 PBD (aa 70–113). Substitution of site II
residues 
135KTS
137 with alanines results in a significant loss of
CIB1 binding to PAK1, further emphasizing the direct interac-
tion between CIB1 and PAK1. Interestingly, these site II resi-
dues lie within a COOH-terminal extension of the IS domain
(aa 136–149) that is referred to as the kinase inhibitor (KI) do-
main (aa 136–149), which is a region that is critical to regulat-
ing PAK1 activation (Lei et al., 2000). The PAK1 crystal
structure indicates that PAK1 exists as a homodimer and that in
the autoinhibited conformation, the KI domain, which con-
tains site I, is positioned within and directly contacts the cata-
lytic cleft of the kinase domain (Lei et al., 2000). Structural
Figure 7. CIB1 modulates downstream signaling to cofilin.
(A) Lysates were prepared from control or specific CIB1
siRNA-transfected REF52 cells either held in suspension
or adhered to FN for the indicated times. Densitometry of
p-cofilin levels from lysates that were prepared from con-
trol or specific CIB siRNA was normalized to ERK or
PAK1 from the same blots. Error bars represent means  
SEM (n   2). (B) Representative membrane immunoblot-
ted with antibodies against total or phosphorylated cofilin
(p-cofilin). The top half of the membrane was also immuno-
blotted for PAK1 expression (bottom). (C) Lysates pre-
pared from REF52 cells overexpressing empty vector or
CIB1   kdPAK1 or kdLIMK1 were analyzed for cofilin
phosphorylation as in A. The membrane was reprobed
for total cofilin (bottom). Lysates from cells expressing
control vector, CIB1, or CIB1 coexpressed with kdPAK1
or kdLIMK1 were immunoblotted using anti-CIB1, -PAK1,
or -LIMK1 antibodies (middle and right). PAK1 immuno-
blots show both endogenous PAK1 and overexpressed
kdPAK1 (top middle). Immunoblotting for LIMK1 also
shows endogenous LIMK1 and overexpressed kdLIMK1
(top right). Middle blots show overexpressed CIB1. Mem-
branes were also probed with an anti-ERK antibody as a
loading control (bottom, middle and right). Data repre-
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information on site I within the context of PAK1 is unknown at
this time because this region was not included in the PAK1
crystal structure. However, nearby NH2-terminal PBD residues
are hypothesized to form initial contacts with Cdc42 as a result
of their relative exposure within the structure (Lei et al., 2000).
Therefore, it is possible that CIB1 binding to PAK1 occurs as a
two-stage event in which CIB1 may initially interact with the
more accessible site I residues and alter the PAK1 conforma-
tion, which would then allow binding within site II to fully
activate PAK1.
Because CIB1 is widely expressed and interacts with a
variety of proteins, it is possible that CIB1 may have different
functions in different cell types. It was recently reported that
overexpression of human CIB1 in CHO cells also overexpress-
ing two additional CIB1 binding partners, Rac3 and integrin
 IIb 3, resulted in  IIb 3-dependent cell spreading on fibrin-
ogen (Haataja et al., 2002). Because the presence of additional
CIB1-binding partners may induce a very different distribution
of CIB1 relative to that found in our cells, which lack endoge-
nous  IIb 3 and also may not express endogenous Rac3, it is
difficult to directly compare these results with our study. Also,
a separate report indicated that stably overexpressed human
CIB1 in CHO cells induced cell migration on FN (Naik and
Naik, 2003). However, the phenotype of the clone that is char-
acterized in this study may represent a clonal variant, or these
cells may express different ratios or combinations of CIB1-
binding proteins. In this study, we determined that transient
overexpression of human CIB1 effectively activated both hu-
man and rat PAK1 but not the closely related PAK3. Although
overexpression studies indicate potential functions of CIB1,
depletion experiments reveal the role of endogenous CIB1. In
agreement with overexpression studies, depletion of CIB1 from
both human (HeLaS3) and rat (REF52) cells resulted in a dra-
matic increase in cell migration, further supporting an inhibi-
tory effect of CIB1 on cell migration.
A fundamental question is how CIB1, via PAK1, regu-
lates actin cytoskeletal dynamics that ultimately impact cell
migration. A potential mechanism is through the activation of a
LIMK- and cofilin-dependent pathway. PAK1 directly acti-
vates LIMK1 via phosphorylation of threonine 508 (Edwards
et al., 1999). Presently, the only known substrate of active
LIMK1 is the actin depolymerizing and severing protein cofilin
(Arber et al., 1998; Yang et al., 1998), which is important for
rapid actin filament turnover and cell motility (Chen et al.,
2001; Dawe et al., 2003). Cofilin activity is negatively regu-
lated by phosphorylation on serine 3, causing accumulation of
F-actin (Moriyama et al., 1996). Recently, active, nonphosphor-
ylated cofilin was shown to set the direction and increase the
rate of cell migration (Ghosh et al., 2004). In agreement with
these studies, we found that depletion of CIB1 results in de-
creased cofilin phosphorylation and increased cell migration,
whereas CIB1 overexpression had the opposite effects. CIB1-
overexpressing cells also typically displayed decreased spreading
with nonpolarized lamellipodia and altered actin polymeriza-
tion, which may have contributed to the observed decrease in
cell migration. Conversely, CIB1-depleted cells showed in-
creased cell polarity and loss of an organized actin cytoskeleton
(in agreement with their increased migratory phenotype), sug-
gesting an important role for CIB1 in modulating cytoskeletal
dynamics (Manser et al., 1998). Moreover, coexpression of ei-
ther DN PAK1 or LIMK1 with CIB1 blocked CIB1-induced
cofilin phosphorylation and rescued cell migration, indicating a
role for PAK1 and LIMK1 in mediating the inhibitory effects
of CIB1 on cell migration. However, unlike LIMK overexpres-
sion, which can promote focal adhesion formation (Edwards et
al., 1999; Sumi et al., 1999), CIB1 overexpression did not in-
crease the number and size of focal adhesions, suggesting that
LIMK1 mediates a subset of the effects of CIB1.
Our finding that CIB1 inhibits cell migration in a PAK1-
dependent manner may seem paradoxical relative to some
other studies in which active PAK1 or Rac and Cdc42 were re-
ported to induce cell migration (Sells et al., 1997, 1999; Ridley
et al., 1999). However, these results are most likely explained
by differences in experimental conditions, because the type and
concentration of ECM can have distinct effects on the cellular
migratory response. Thus, our results are consistent with
Kiosses et al. (1999), who showed that active PAK1 inhibits
endothelial cell migration, and with Sander et al. (1999), who
found that active Rac inhibits MDCK cell migration on rela-
tively low concentrations of FN (2–10  g/ml). Specifically, we
found that overexpression of either PAK1 or CIB1 inhibited
both REF52 and NIH3T3 cell migration toward low FN con-
centrations (Fig. S3, A and B). Importantly, overexpression of
CIB1 in PAK1-null MEFs, unlike wild-type MEFs, did not
suppress cell migration on low concentrations of FN, further
demonstrating the requirement of PAK1 in CIB1-induced inhi-
bition of cell migration (Fig. 5 B). In contrast, in studies in
which PAK1 or Rac/Cdc42 induced cell migration, either rela-
tively high FN concentrations (e.g., 50  g/ml) or different sub-
strates (e.g., collagen) were used and, therefore, may reflect
differences in integrin engagement and signaling. Additional
studies are underway to determine how CIB1 affects cell mi-
gration across different ECM substrates.
Several lines of evidence indicate that the interaction of
PAK1 with CIB1 versus Rac/Cdc42 may be temporally regu-
lated and, thus, differentially impact downstream signaling
pathways. First, with extended times of adhesion to FN, control
cells continued to exhibit PAK1-dependent cofilin phosphory-
lation (Fig. 7, A–C). Second, this phosphorylation also ap-
peared to involve a CIB1-dependent component because CIB1
depletion significantly decreased cofilin phosphorylation at all
times examined (Fig. 7, A and B). Third, adhesion-induced
PAK1 and cofilin activation were not inhibited by the coex-
pression of DN Rac and Cdc42. However, with extended adhe-
sion to FN, PAK1 (Fig. S3 A) and cofilin (Fig. S3 C) activity
decreased in cells coexpressing DN Rac and Cdc42. These
findings are of interest because Rac and Cdc42 are currently
the only known activators of PAK1 upon cell adhesion (Price
et al., 1998; del Pozo et al., 2000). However, our results sug-
gest a model in which the activation of PAK1 upon cell adhe-
sion to FN transitions from a CIB1-dependent to a more
Cdc42/Rac-dependent process. Furthermore, CIB1 depletion
resulted in increased Cdc42 but not in Rac activity, and this
increased Cdc42 activity correlated with extensive filopodiaJCB • VOLUME 170 • NUMBER 3 • 2005 474
formation and increased cell polarity (Fig. 7 C), suggesting a
disregulation of GTPase signaling. Altogether, these results
suggest that Rac/Cdc42 may mediate PAK1-dependent signal-
ing in a manner temporally distinct from that of CIB1 and that
this temporal and spatial regulation of the interaction of PAK1
with different upstream activators can ultimately affect the
coupling  of PAK1 to specific downstream signaling compo-
nents. Thus, the differential regulation of PAK1 by CIB1 relative
to Cdc42/Rac appears to be important in modulating cytoskeletal
dynamics and cell migration.
In conclusion, we found that CIB1 binds to and activates
PAK1 both in vitro and in vivo and that this interaction is re-
quired for the normal temporal sequence of adhesion-induced
PAK1 activation. Although Cdc42 and Rac bind multiple PAK
isoforms, CIB1 shows preferential binding to PAK1. The speci-
ficity of CIB1 for PAK1 may define a unique Ca
2 -dependent
PAK1 signaling pathway that leads to the phosphorylation and
deactivation of cofilin, resulting in the inhibition of cell migra-
tion. Further study of CIB1 and its relationship to PAK1, as well
as other binding partners, will provide a greater understanding
of cytoskeletal regulation and migration in both normal and
pathological conditions such as metastases and invasion.
Materials and methods
Platelet preparation and immunoprecipitation 
Washed platelets were prepared as previously described (Shock et al.,
1999), were resuspended to 4–8   10
8 platelets/ml in Tyrode’s buffer
without inhibitors or BSA, and were lysed with CHAPS lysis buffer (20 mM
Hepes, pH 7.4, 0.15 M NaCl, 10 mM CHAPS, 0.5% deoxycholate, 50
mM NaF, 1 mM NaVO3, 10 mM sodium pyrophosphate, Protease Inhibitor
Cocktail Set III [Calbiochem-Novabiochem], and 1 mM each of CaCl2 and
MgCl2). Clarified lysates were incubated with control IgY or with chicken
polyclonal anti-CIB1 antibodies, and immune complexes were isolated with
anti–chicken IgY–conjugated agarose (Promega). Samples were immuno-
blotted with either a polyclonal antiphosphoserine (Zymed Laboratories) or
with an anti- PAK antibody (Santa Cruz Biotechnology, Inc.).
Recombinant proteins and in vitro kinase assays 
Recombinant GST-CIB1, -PAK1, and -PAK2 were purified, and the GST
tag was removed and separated from CIB1 as described previously
(Shock et al., 1999). GST-PAK1 mutants were provided by M. Cobb (Uni-
versity of Texas Southwestern Medical Center, Dallas, TX) and were puri-
fied as described previously (Frost et al., 1997). The His-tagged wild-type
PAK1 construct was provided by G. Bokoch (Scripps Research Institute, La
Jolla, CA) and was purified under native conditions as described previ-
ously (Zenke et al., 1999). Kinase reactions with recombinant His-PAK1,
CIB1, and GTP/GDP-loaded Cdc42 (provided by J. Sondek, University of
North Carolina [UNC], Chapel Hill, NC) were performed as described
previously (Zenke et al., 1999), stopped with 6  sample buffer, and sep-
arated by SDS-PAGE. Coomassie blue–stained gels were dried, and sam-
ples were visualized by autoradiography.
In vitro binding assays 
Microtiter wells were coated with and without 5  g/ml CIB1 overnight at
RT and were blocked with 3% BSA. 50  l/well PAK proteins were added
for 1 h at 37 C. For inhibition studies, 7  g/ml His-PAK1 was incubated
for 30 min with soluble CIB1 or Cdc42 that was preloaded with GDP or
GTP S before addition to wells coated with and without CIB1. For Ca
2 -
dependent binding studies, His-PAK1 was diluted in buffer containing 1  M
Ca
2  with increasing concentrations of EGTA (0–5  M) before addition to
CIB1-coated wells. In all cases, wells were washed with TBS containing
0.05% Tween 20, and PAK1 binding was detected with an anti-His or
anti-GST antibody (Santa Cruz Biotechnology, Inc.) followed by HRP-con-
jugated sheep anti–mouse IgG (GE Healthcare). The reactions were devel-
oped by using o-phenylenediamine as a substrate, and absorbance was
measured at 490 nm (OD490). To assess the effects of PAK1 peptides on
CIB1–PAK1 binding, 0.5  g/ml CIB1 was preincubated for 30 min at
22 C with and without 5  M PAK1 peptides. His-PAK1 coupled to Ni-
NTA agarose (QIAGEN) was then added to the CIB1/peptide samples
and were mixed for 1 h at 22 C. His-PAK1 beads were washed with 20
mM Hepes/saline, pH 7.4, with 0.05% Tween 20, prepared for SDS-
PAGE, and immunoblotted for CIB1. The top half of the membrane was
also blotted for His-PAK1 as a loading control.
CIB1-binding site characterization
The CIB1-binding site on PAK1 was identified by using SPOT peptide tech-
nology (Frank, 2002). Peptides of the first 164 amino acids of the PAK1
NH2 terminus were synthesized as 12mers that overlapped by seven
amino acids, were spotted onto nitrocellulose (gift from F. Gertler, Massa-
chusetts Institute of Technology, Cambridge, MA), and were incubated
with 2  g/ml CIB1 diluted in 20 mM Hepes, pH 7.4, 150 mM NaCl, 1
mM CaCl2, 1 mM MgCl2, 0.5% BSA, and 5% glycerol. After three
washes, CIB1 binding was detected with a chicken polyclonal anti-CIB1
IgY followed by HRP-conjugated donkey anti-IgY (Jackson ImmunoRe-
search Laboratories).
Generation and immunoprecipitation of Pak1 mutants 
The QuikChange Site-Directed Mutagenesis Kit (Stratagene) was used to
generate the myc-PAK1 siteIIAAA (AAA myc-PAK1, aa 135–137/AAA).
Primers for the triple mutations are listed as follows (mutated sites are
in bold face): forward primer, 5 -GTTTTACAACTCGAAGGCGGCAGCC-
AACAGCCAGAAATAC-3 ; and reverse primer, 5 -GTATTTCTGGCTGT-
TGGCTGCCGCCTTCGAGTTGTAAAAC-3 . Myc-PAK1 siteI /siteIIAAA
( /AAA myc-PAK1) mutant with deletion of aa 8–68 was generated by
PCR using pfu Turbo (Stratagene) with an ExSite PCR-based site-directed
mutagenesis strategy (Stratagene). Primers for generating Pak1 8–68 are
listed as follows: forward primer, 5 -GTCTAGGCCGTTATTTGA-3 ; and re-
verse primer, 5 -GAGAAAGAGCGGCCAGAG-3 . For coimmunoprecipi-
tation experiments, HEK293 cells were cotransfected with CIB1 and myc-
tagged wild-type or mutant PAK1 using LipofectAMINE 2000 (Invitrogen).
CIB1 was immunoprecipitated from clarified lysates by using a mAb anti-
CIB1 (UN2), and the immunoprecipitates were immunoblotted with anti-
myc (Santa Cruz Biotechnology, Inc.) and anti-CIB1 antibodies.
Cell culture and immunohistochemistry 
Cells were maintained in DME (REF52 and HEK293) and Ham’s F-12
(HeLaS3) media supplemented with 10% FBS. MEFs were isolated from
day 13.5 wild-type or Pak1
 /  embryos. Wild-type and Pak1
 /  MEFs
were immortalized with SV40 T antigen and were maintained in DME sup-
plemented with 12% FBS. Plasmids encoding V5 epitope–tagged kinase-
inactive K299R and ca T423E PAK1(gift of R. Juliano, UNC, Chapel Hill,
NC), kinase-inactive LIMK1 D460N (gift of G. Bokoch), and wild-type
CIB1 in pcDNA3.1 were transiently transfected into REF52 cells with Lipo-
fectAMINE Plus (Invitrogen). Cells were serum starved 30 h posttransfec-
tion, harvested by trypsinization, and added to DME containing 2 mg/ml
of soybean trypsin inhibitor and 0.2% delipidated BSA. After washing,
cells were resuspended in DME/0.2% BSA and were incubated for 1 h in
suspension before assays. For immunostaining, REF52 cells were seeded
onto coverslips coated with 10  g/ml FN and were allowed to adhere for
various times at 37 C. Cells were permeabilized with 0.2% Triton X-100
in PBS, blocked with normal serum, and stained with antibodies raised
against CIB1 (chicken pAb anti-CIB1 or UN2) and vinculin (Sigma-
Aldrich). Polymerized actin was visualized with AlexaFluor594 phalloidin
(Molecular Probes). Goat anti–mouse AlexaFluor594, goat anti–chicken
AlexaFluor488, and goat anti–mouse AlexaFluor488 (Molecular Probes)
were used as secondary antibodies. Images were collected using a laser
scanning confocal imaging system (Fluoview 300; Olympus) that was con-
figured with a fluorescence microscope (model IX70; Olympus) fitted with
a 60  oil objective (PlanApo; Olympus). Confocal images were pro-
cessed using Adobe Photoshop.
Migration assays 
Haptotactic migration was performed using 8- m pore polycarbonate
transwell membranes (Costar) coated on the underside with 5 (REF52) or
20   g/ml FN (HeLaS3), and 5–7.5   10
4 serum-starved cells were
added to the top chamber. For siRNA depletion studies, nonmigrating
cells were removed from the top membrane surface, and migrated cells
were fixed and stained with the Diff-Quik Stain Kit (Dade Behring). Cells
from 10 fields per membrane were counted and averaged. For overex-
pression studies, transfected cells on the top (nonmigrating cells) or bottom
(migrating cells) membrane were fixed and visualized by GFP expression,
by immunostaining with antibodies directed against CIB1 alone, by CIB1
with PAK1 (anti-V5 epitope; Bethyl Labs), or by LIMK1 (Santa Cruz Bio-CIB1 ACTIVATION OF PAK1 REGULATES CELL MIGRATION • LEISNER ET AL. 475
technology, Inc.). Cells were also stained with phalloidin to detect the total
cell number. Images were collected using laser scanning confocal imaging
as described above with a 10  objective (PlanApo; Olympus). Cells were
counted under 20 , and transfected cells migrating to the underside of
the membrane were represented as the percentage of the total number of
transfected cells.
PAK1 kinase and Rac/Cdc42 activation assays 
Serum-starved transfected cells were held in suspension or were seeded
onto tissue culture plates coated with 10  g/ml FN. Lysates were pre-
pared by the addition of ice-cold 1% NP-40 lysis buffer as described in
Platelet preparation and immunoprecipitation, but with the addition of
10% glycerol and 0.2 mM pervanadate. Equal amounts of lysate protein
on Western blots were probed with total and phosphospecific anticofilin
antibodies (Cytoskeleton, Inc. and Santa Cruz Biotechnology, Inc., respec-
tively). Lysates were also subjected to immunoprecipitation with either an
NH2-terminal–specific anti-PAK1 or -PAK3 antibody (Santa Cruz Biotech-
nology, Inc.). Immunoprecipitated PAK kinase activity was assayed using
myelin basic protein as the substrate (Zenke et al., 1999). Activated
Cdc42/Rac1 was assayed using the GST-fusion protein of PAK PBD (GST-
PBD; aa 70–132), which binds specifically to active GTP-bound Rac and
Cdc42 (del Pozo et al., 2000). Immobilized GST-PBD was provided by K.
Burridge (UNC, Chapel Hill, NC). Affinity-precipitated and total Rac1 and
Cdc42 were detected by Western blotting with antibodies against Rac1
and Cdc42 (Santa Cruz Biotechnology, Inc.).
siRNA 
RNA interference for human CIB1 was performed as described previously
(Elbashir et al., 2001). CIB1 siRNA oligonucleotides 5 -AAGCAG-
GAGATCCTCCTAGCC(TT)-3  (corresponding to bases 136–156) or 5 -
AAGAGTCACTGCATACCCGAG(TT)-3  (bases 177–197) within the
human or rat cDNA ORFs, respectively (Dharmacon Research), were trans-
fected at a final concentration of 80 (REF52) and 60 nM (HeLaS3) by us-
ing a TransIT-TKO or SiQuest reagent (Mirus). Assays were performed
48–72 h posttransfection.
Online supplemental material
Fig. S1 shows in vivo activation of PAK1 by CIB1 and a comparison of the
CIB1-binding sites in human and rat PAK1 versus PAK3. Fig. S2 provides
evidence for Ca
2 -dependent PAK1 activation in adherent cells. Fig. S3
shows the effects of DN GTPases on signaling to PAK1 and cofilin. Fig. S4
shows the effects of CIB1 overexpression on cell spreading, actin dynam-
ics, and colocalization with PAK1. Fig. S5 provides additional evidence
for PAK1 activity in inhibiting REF52 and NIH3T3 cell migration. Online
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200502090/DC1.
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